Provided by Tiger Trade Technology Pte. Ltd.

CH BIOTECH SER

0.620
+0.0152.48%
Volume:40.00K
Turnover:24.50K
Market Cap:604.95M
PE:-8.80
High:0.620
Open:0.600
Low:0.600
Close:0.605
52wk High:1.210
52wk Low:0.300
Shares:975.73M
HK Float Shares:975.73M
Volume Ratio:0.29
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.070
ROE:-40.61%
ROA:-7.49%
PB:3.16
PE(LYR):-8.80
PS:8.23

Loading ...

China Biotech Services Holdings Turns Profitable in First Half with HK$18.23 Million Net Gain

Stock News
·
Aug 29

China Biotech Services Swings to FY26 H1 Profit of HK$ 15.06 Million; Revenue Rises 49.7% to HK$ 37.23 Million

Reuters
·
Aug 28

China Biotech Services - Revenue from Cont Ops for Six Months Ended June 30, 2026 Hk$37.23 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Hy Profit Attributable Hk$18.2 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Board Has Resolved not to Declare Any Dividend for Period Ended 30 June 2026

THOMSON REUTERS
·
Aug 28

China Biotech Services Completes Disposal of PHC and PMS, Accelerates Pivot to BNCT Platform

Bulletin Express
·
Aug 13

China Biotech Services Completes Sale of PHC Medical Diagnostic Centre, Premier Medicare Services Shares

Reuters
·
Aug 13

China Biotech Services Expects H1 Net Profit of at Least HK$15 Million, Swings from Loss

Reuters
·
Aug 12

China Biotech Services forecasts ≥ HK$15.00 million interim profit, reversing prior HK$37.00 million loss on convertible-bond revaluation gains

Bulletin Express
·
Aug 12

China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express
·
Aug 12

China Biotech Services - Expects Net Profit of not Less than Hk$15.0 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 12

China Biotech Services - Expected Hy Net Profit Mainly Due to Fair Value Gain on Convertible Bonds of HK$77-87 Mln

THOMSON REUTERS
·
Aug 12

China Biotech Services - Stella Pharma Grants Exclusive Royalty-Free License to Co to Develop Steboronine in the PRC

THOMSON REUTERS
·
Aug 12

China Biotech Services - Enters Master Collaboration Agreement with Stella Pharma on Aug 11, 2026

THOMSON REUTERS
·
Aug 12

CH BIOTECH SER Finalises BGI Songhe’s 6.25% Stake in Pengbo (Hainan) Subsidiary

Bulletin Express
·
Aug 07

Big Shipment for Chinese Biotech Services: Strategic Partner Takes Stake in Key Subsidiary

Stock News
·
Aug 07

CH BIOTECH SER: July 2026 Share Base Unchanged; Convertibles Allow for Up to 455 Million New Shares

Bulletin Express
·
Aug 04

China Biotech Services Updates GEM Information Sheet; Chairman Controls 54.75% and US$41 Million Convertible Bonds Remain Outstanding

Bulletin Express
·
Aug 03

Breakthrough BNCT Data: 80% Response Rate in Late-Stage Head and Neck Cancer Patients Treated at Hainan Boron Neutron Hospital

Stock News
·
Aug 03

China Biotech Services to Relocate Bermuda Registered Office and Principal Share Registrar on 3 August 2026

Bulletin Express
·
Jul 28